Literature DB >> 24518409

Side-to-end hypoglossal to facial anastomosis with transposition of the intratemporal facial nerve.

William H Slattery1, Adam M Cassis, Eric P Wilkinson, Felipe Santos, Karen Berliner.   

Abstract

OBJECTIVE: To describe results in a large series of patients using a recent variation of hypoglossal-facial nerve anastomosis (HFA) in which the intratemporal facial nerve segment is used, obviating the need for a sensory nerve "jump graft." STUDY
DESIGN: Retrospective chart review.
SETTING: Tertiary neurotologic referral center. PATIENTS: Nineteen patients (12 female/7 male subjects) with facial paralysis because of posterior fossa surgery for tumor (n = 15), Bell's palsy (n = 1), facial neuroma (n = 1), hemangioma (n = 1), and trauma (n = 1) who underwent HFA from 1997 to 2011, with at least 1-year follow-up. Mean age at surgery is 47.4 years (range, 11.2-83 yr). Mean follow-up is 4.0 years. INTERVENTION: Side-to-end hypoglossal to facial anastomosis with transposition of the intratemporal facial nerve (swingdown HFA). MAIN OUTCOME MEASURE: House-Brackmann (H-B) facial nerve grade.
RESULTS: Seven patients (36.8%) achieved an H-B Grade III, 9 patients (47.4%) a grade IV, and 3 patients (15.8%) a grade V at last follow-up. No patients complained of dysphagia, dysarthria, or had evidence of oral incompetence. One patient complained of mild tongue weakness. Age at time of HFA (p ≤ 0.049, III younger than V) and time from facial nerve injury to HFA (p ≤ 0.02, III<IV and V) were significant factors for ultimate facial nerve outcome. All patients with an H-B III result had HFA within 6 months of injury. Other factors were not significant.
CONCLUSION: The HFA swingdown technique is a safe and effective method to restore facial nerve function in patients with facial paralysis and obviates the need for an interposition jump graft.

Entities:  

Mesh:

Year:  2014        PMID: 24518409     DOI: 10.1097/MAO.0b013e3182936bcf

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  6 in total

1.  Comparison between VII-to-VII and XII-to-VII coaptation techniques for early facial nerve reanimation after surgical intra-cranial injuries: a systematic review and pooled analysis of the functional outcomes.

Authors:  Luca Ricciardi; Vito Stifano; Resi Pucci; Vittorio Stumpo; Nicola Montano; Marco Della Monaca; Liverana Lauretti; Alessandro Olivi; Valentino Valentini; Carmelo Lucio Sturiale
Journal:  Neurosurg Rev       Date:  2020-01-07       Impact factor: 3.042

2.  EANO guideline on the diagnosis and treatment of vestibular schwannoma.

Authors:  Roland Goldbrunner; Michael Weller; Jean Regis; Morten Lund-Johansen; Pantelis Stavrinou; David Reuss; D Gareth Evans; Florence Lefranc; Kita Sallabanda; Andrea Falini; Patrick Axon; Olivier Sterkers; Laura Fariselli; Wolfgang Wick; Joerg-Christian Tonn
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

3.  Hemihypoglossal-facial nerve anastomosis: results and electromyographic characterization.

Authors:  Zdeněk Fík; Josef Kraus; Zdeněk Čada; Martin Chovanec; Alžběta Fíková; Eduard Zvěřina; Jan Betka; Jan Plzák
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-05-25       Impact factor: 2.503

Review 4.  Diagnostics and therapy of vestibular schwannomas - an interdisciplinary challenge.

Authors:  Steffen Rosahl; Christopher Bohr; Michael Lell; Klaus Hamm; Heinrich Iro
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2017-12-18

5.  Results of End-To-Side Hypoglossal-Facial Nerve Anastomosis in Facial Paralysis after Skull Base Surgery.

Authors:  Sasan Dabiri; Mohammadtaghi Khorsandi Ashtiani; Melorina Moharreri; Zahra Mahvi Khomami; Ali Kouhi; Nasrin Yazdani; Pedram Borghei; Kayvan Aghazadeh
Journal:  Iran J Otorhinolaryngol       Date:  2020-05

6.  Outcome of different facial nerve reconstruction techniques.

Authors:  Aboshanif Mohamed; Eigo Omi; Kohei Honda; Shinsuke Suzuki; Kazuo Ishikawa
Journal:  Braz J Otorhinolaryngol       Date:  2016-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.